- Q1 2024 Merck KGaA Earnings Call TranscriptMay 15, 2024€165.78 (+4.47%)Earnings
- Q4 2023 Merck KGaA Earnings Press Conference TranscriptMar 07, 2024
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Merck KGaA Earnings Call TranscriptNov 09, 2023€153.83 (+3.52%)Earnings
- Merck KGaA Capital Markets Day TranscriptOct 19, 2023
- Q2 2023 Merck KGaA Earnings Call TranscriptAug 03, 2023€163.78 (+3.26%)Earnings
- Q2 2023 Merck KGaA Earnings Press Conference TranscriptAug 03, 2023
- Q1 2023 Merck KGaA Earnings Call TranscriptMay 11, 2023€165.65 (+2.79%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 28, 2023
- Q4 2022 Merck KGaA Earnings Call TranscriptMar 02, 2023€179.83 (+1.64%)Earnings
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Merck KGaA R&D Update Call TranscriptNov 21, 2022
- Q3 2022 Merck KGaA Earnings Call TranscriptNov 10, 2022€177.43 (+3.83%)Earnings
- Merck KGaA Capital Markets Day TranscriptOct 06, 2022
- Q2 2022 Merck KGaA Earnings Call TranscriptAug 04, 2022€184.88 (+0.56%)Earnings
- Q1 2022 Merck KGaA Earnings Call TranscriptMay 12, 2022€160.73 (-5.15%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 22, 2022
- Full Year 2021 Merck KGaA Earnings Call TranscriptMar 03, 2022€176.35 (+0.99%)Earnings
- Merck KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Merck KGaA R&D Update Call TranscriptNov 22, 2021
- Q3 2021 Merck KGaA Earnings Call TranscriptNov 11, 2021€205.5 (-0.36%)Earnings
- Merck KGaA Capital Markets Day (Virtual) TranscriptSep 09, 2021
- Half Year 2021 Merck KGaA Earnings Call TranscriptAug 05, 2021€188.03 (+6.56%)Earnings
- Q1 2021 Merck KGaA Earnings Call TranscriptMay 12, 2021€135.53 (-1.81%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 23, 2021
- Full Year 2020 Merck KGaA Earnings Call TranscriptMar 04, 2021€133.2 (+0.68%)Earnings
- Merck KGaA Bintrafusp alfa 037 Ad-Hoc - Capital Markets Q&A Call TranscriptJan 20, 2021
- Merck KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Merck KGaA at PR Newswire and BetterInvesting (NAIC) Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 19, 2020
- Q3 2020 Merck KGaA Earnings Call TranscriptNov 12, 2020€130.7 (-0.63%)Earnings
- Merck KGaA CMD - Healthcare:R&D Update Call TranscriptSep 25, 2020
- Merck KGaA Capital Markets Day (virtual) - Performance Materials: Semiconductor Solutions TranscriptSep 16, 2020
- Merck KGaA Capital Markets Day (virtual) - Life Science: Process Solutions TranscriptSep 16, 2020
- Merck KGaA Capital Markets Day (virtual) - CEO/CFO Session and Board Q&A TranscriptSep 16, 2020
- Half Year 2020 Merck KGaA Earnings Call TranscriptAug 06, 2020€113.08 (+1.44%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Merck KGaA Earnings Call TranscriptMay 14, 2020€103.25 (-3.14%)Earnings
- Merck KGaA at PR Newswire and BetterInvesting (NAIC) Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptMar 18, 2020
- Full Year 2019 Merck KGaA Earnings Call TranscriptMar 05, 2020€115.35 (+1.27%)Earnings
- Merck KGaA Evobrutinib (RMS) Update Call TranscriptFeb 20, 2020
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Merck KGaA Earnings Call TranscriptNov 14, 2019€106.03 (-3.39%)Earnings
- Merck KGaA Capital Market Day TranscriptSep 11, 2019
- Half Year 2019 Merck KGaA Earnings Call TranscriptAug 08, 2019€94.38 (+1.66%)Earnings
- Merck KGaA R&D Update Call TranscriptJun 14, 2019
- Oncolytics Biotech Inc. - Shareholder/Analyst Call TranscriptJun 05, 2019
- Q1 2019 Merck KGaA Earnings Call TranscriptMay 14, 2019€92.09 (-3.55%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 26, 2019
- Merck KGaA Signs Definitive Agreement to Acquire Versum Materials Call TranscriptApr 12, 2019
- Merck KGaA FDA Approval of MAVENCLAD Conference Call TranscriptApr 01, 2019
- Full Year 2018 Merck KGaA Earnings Call TranscriptMar 07, 2019€93.23 (-0.03%)Earnings
Merck KGaA at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, good afternoon, and welcome to the 39th JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. And it gives me great pleasure to introduce Stefan Oschmann, CEO of Merck KGaA from Germany in -- Darmstadt in Germany for this first presentation at the conference.
Before I hand over to Stefan, I will remind you that if you would like to ask a question during the Q&A portion of this session, then you can use the Q&A function at any time associated on the conference website, and I will read out your question from there. With that, I'd like to welcome Stefan to the conference. Stefan, over to you. Welcome.
Thank you, Richard, and many thanks to JPMorgan for the invite. Dear ladies and gentlemen, a very warm welcome and a happy and healthy new year to all of you, both from my side as well as on behalf of my colleagues joining me for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)